|

Bel-sar Clinical Trials

1 actively recruiting trial across 1 location

Also known as: AU-011

Pipeline

Phase 3: 1

Top Sponsors

  • Aura Biosciences1

Indications

  • Indeterminate Lesions1
  • Choroidal Melanoma1
  • Ocular Melanoma1
  • Uveal Melanoma1
  • Cancer1

Birmingham, Alabama1 trial

A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

Retina Consultants of Alabama

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.